Evidence map›Paper›PMID 26345660›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2015

Curcumin Attenuates Gentamicin-Induced Kidney Mitochondrial Alterations: Possible Role of a Mitochondrial Biogenesis Mechanism.

Mario Negrette-Guzmán, Wylly Ramsés García-Niño, Edilia Tapia, Cecilia Zazueta, Sara Huerta-Yepez, Juan Carlos León-Contreras, Rogelio Hernández-Pando, Omar Emiliano Aparicio-Trejo, Magdalena Madero, José Pedraza-Chaverri

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. A Flavonoid-Rich Extract ofMaterials (Basel, Switzerland) · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Mario Negrette-GuzmánDepartamento de Biología, Facultad de Química, UNAM, 04510 Ciudad de México, DF, Mexico.
Wylly Ramsés García-NiñoDepartamento de Biomedicina Cardiovascular, Instituto Nacional de Cardiología "Ignacio Chávez", 14080 Ciudad de México, DF, Mexico.
Edilia TapiaLaboratorio de Fisiopatología Renal, Instituto Nacional de Cardiología "Ignacio Chávez", 14080 Ciudad de México, DF, Mexico.
Cecilia ZazuetaDepartamento de Biomedicina Cardiovascular, Instituto Nacional de Cardiología "Ignacio Chávez", 14080 Ciudad de México, DF, Mexico.
Sara Huerta-YepezUnidad de Investigación en Enfermedades Oncológicas, Hospital Infantil de México "Federico Gómez", 06720 Ciudad de México, DF, Mexico.
Juan Carlos León-ContrerasDepartamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", 14000 Ciudad de México, DF, Mexico.
Rogelio Hernández-PandoDepartamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", 14000 Ciudad de México, DF, Mexico.
Omar Emiliano Aparicio-TrejoDepartamento de Biología, Facultad de Química, UNAM, 04510 Ciudad de México, DF, Mexico.
Magdalena MaderoDepartamento de Nefrología, Instituto Nacional de Cardiología "Ignacio Chávez", 14080 Ciudad de México, DF, Mexico.
José Pedraza-ChaverriDepartamento de Biología, Facultad de Química, UNAM, 04510 Ciudad de México, DF, Mexico.
Instituto Nacional de Cardiología · MXUniversidad Nacional Autónoma de México · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXHospital Infantil de México Federico Gómez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been shown that curcumin (CUR), a polyphenol derived from Curcuma longa, exerts a protective effect against gentamicin- (GM-) induced nephrotoxicity in rats, associated with a preservation of the antioxidant status. Although mitochondrial dysfunction is a hallmark in the GM-induced renal injury, the role of CUR in mitochondrial protection has not been studied. In this work, LLC-PK1 cells were preincubated 24 h with CUR and then coincubated 48 h with CUR and 8 mM GM. Treatment with CUR attenuated GM-induced drop in cell viability and led to an increase in nuclear factor (erythroid-2)-related factor 2 (Nrf2) nuclear accumulation and peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) cell expression attenuating GM-induced losses in these proteins. In vivo, Wistar rats were injected subcutaneously with GM (75 mg/Kg/12 h) during 7 days to develop kidney mitochondrial alterations. CUR (400 mg/Kg/day) was administered orally 5 days before and during the GM exposure. The GM-induced mitochondrial alterations in ultrastructure and bioenergetics as well as decrease in activities of respiratory complexes I and IV and induction of calcium-dependent permeability transition were mostly attenuated by CUR. Protection of CUR against GM-induced nephrotoxicity could be in part mediated by maintenance of mitochondrial functions and biogenesis with some participation of the nuclear factor Nrf2.

Identifiers

PMID26345660
PMCPMC4541007
OpenAlexW1557865674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.